These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11838622)

  • 1. An open-label trial of sibutramine in obese patients with binge-eating disorder.
    Appolinario JC; Godoy-Matos A; Fontenelle LF; Carraro L; Cabral M; Vieira A; Coutinho W
    J Clin Psychiatry; 2002 Jan; 63(1):28-30. PubMed ID: 11838622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder.
    Appolinario JC; Bacaltchuk J; Sichieri R; Claudino AM; Godoy-Matos A; Morgan C; Zanella MT; Coutinho W
    Arch Gen Psychiatry; 2003 Nov; 60(11):1109-16. PubMed ID: 14609886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of sibutramine, an inhibitor of the reuptake of serotonin and noradrenaline, in the treatment of binge eating disorder: a placebo-controlled study.
    Milano W; Petrella C; Casella A; Capasso A; Carrino S; Milano L
    Adv Ther; 2005; 22(1):25-31. PubMed ID: 15943219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind study.
    Wilfley DE; Crow SJ; Hudson JI; Mitchell JE; Berkowitz RI; Blakesley V; Walsh BT;
    Am J Psychiatry; 2008 Jan; 165(1):51-8. PubMed ID: 18056225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate use in obese patients with binge eating disorder: an open study.
    Appolinario JC; Fontenelle LF; Papelbaum M; Bueno JR; Coutinho W
    Can J Psychiatry; 2002 Apr; 47(3):271-3. PubMed ID: 11987480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venlafaxine treatment of binge-eating disorder associated with obesity: a series of 35 patients.
    Malhotra S; King KH; Welge JA; Brusman-Lovins L; McElroy SL
    J Clin Psychiatry; 2002 Sep; 63(9):802-6. PubMed ID: 12363121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity, binge eating and psychopathology: are they related?
    Telch CF; Agras WS
    Int J Eat Disord; 1994 Jan; 15(1):53-61. PubMed ID: 8124327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of patients with bulimia nervosa, obese patients with binge eating disorder, and nonobese patients with binge eating disorder.
    Barry DT; Grilo CM; Masheb RM
    J Nerv Ment Dis; 2003 Sep; 191(9):589-94. PubMed ID: 14504568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of sibutramine and of cognitive-behavioural weight loss therapy in obesity and subclinical binge eating disorder.
    Bauer C; Fischer A; Keller U
    Diabetes Obes Metab; 2006 May; 8(3):289-95. PubMed ID: 16634988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of DSM-IV personality pathology among individuals with bulimia nervosa, binge eating disorder and obesity.
    van Hanswijck de Jonge P; Van Furth EF; Lacey JH; Waller G
    Psychol Med; 2003 Oct; 33(7):1311-7. PubMed ID: 14580084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Obesity, alexithymia, psychopathology and binge eating: a comparative study of 40 obese patients and 32 controls].
    De Chouly De Lenclave MB; Florequin C; Bailly D
    Encephale; 2001; 27(4):343-50. PubMed ID: 11686056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing cognitive behavioural therapy for eating disorders integrated with behavioural weight loss therapy to cognitive behavioural therapy-enhanced alone in overweight or obese people with bulimia nervosa or binge eating disorder: study protocol for a randomised controlled trial.
    Palavras MA; Hay P; Touyz S; Sainsbury A; da Luz F; Swinbourne J; Estella NM; Claudino A
    Trials; 2015 Dec; 16():578. PubMed ID: 26683478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binge eating and psychopathology in severely obese adolescents.
    Isnard P; Michel G; Frelut ML; Vila G; Falissard B; Naja W; Navarro J; Mouren-Simeoni MC
    Int J Eat Disord; 2003 Sep; 34(2):235-43. PubMed ID: 12898560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zonisamide in the treatment of binge-eating disorder: an open-label, prospective trial.
    McElroy SL; Kotwal R; Hudson JI; Nelson EB; Keck PE
    J Clin Psychiatry; 2004 Jan; 65(1):50-6. PubMed ID: 14744168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of binge eating disorder and psychiatric comorbidity in obese subjects.
    Yanovski SZ; Nelson JE; Dubbert BK; Spitzer RL
    Am J Psychiatry; 1993 Oct; 150(10):1472-9. PubMed ID: 8379549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sibutramine on binge eating, hunger, and fullness in a laboratory human feeding paradigm.
    Mitchell JE; Gosnell BA; Roerig JL; de Zwaan M; Wonderlich SA; Crosby RD; Burgard MA; Wambach BN
    Obes Res; 2003 May; 11(5):599-602. PubMed ID: 12740447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of bulimics, obese binge eaters, social phobics, and individuals with panic disorder on comorbidity across DSM-III-R anxiety disorders.
    Schwalberg MD; Barlow DH; Alger SA; Howard LJ
    J Abnorm Psychol; 1992 Nov; 101(4):675-81. PubMed ID: 1430607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical differences between morbid obese patients with and without binge eating].
    Arias Horcajadas F; Sánchez Romero S; Gorgojo Martínez JJ; Almódovar Ruiz F; Fernández Rojo S; Llorente Martin F
    Actas Esp Psiquiatr; 2006; 34(6):362-70. PubMed ID: 17117332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The assessment of binge eating disorder in obese women: a comparison of the binge eating scale with the structured clinical interview for the DSM-IV.
    Freitas SR; Lopes CS; Appolinario JC; Coutinho W
    Eat Behav; 2006 Aug; 7(3):282-9. PubMed ID: 16843232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term effects of sibutramine (Reductil) on appetite and eating behaviour and the long-term therapeutic outcome.
    Barkeling B; Elfhag K; Rooth P; Rössner S
    Int J Obes Relat Metab Disord; 2003 Jun; 27(6):693-700. PubMed ID: 12833113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.